AR225314A1 - Procedimiento para la preparacion de nuevos derivados de indolizina - Google Patents

Procedimiento para la preparacion de nuevos derivados de indolizina

Info

Publication number
AR225314A1
AR225314A1 AR281618A AR28161880A AR225314A1 AR 225314 A1 AR225314 A1 AR 225314A1 AR 281618 A AR281618 A AR 281618A AR 28161880 A AR28161880 A AR 28161880A AR 225314 A1 AR225314 A1 AR 225314A1
Authority
AR
Argentina
Prior art keywords
procedure
preparation
indolizine derivatives
new indolizine
new
Prior art date
Application number
AR281618A
Other languages
English (en)
Original Assignee
Labaz Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Labaz Nv filed Critical Labaz Nv
Application granted granted Critical
Publication of AR225314A1 publication Critical patent/AR225314A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
AR281618A 1979-07-06 1980-07-02 Procedimiento para la preparacion de nuevos derivados de indolizina AR225314A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7923599 1979-07-06

Publications (1)

Publication Number Publication Date
AR225314A1 true AR225314A1 (es) 1982-03-15

Family

ID=10506339

Family Applications (1)

Application Number Title Priority Date Filing Date
AR281618A AR225314A1 (es) 1979-07-06 1980-07-02 Procedimiento para la preparacion de nuevos derivados de indolizina

Country Status (24)

Country Link
US (1) US4400387A (es)
EP (1) EP0022762B1 (es)
JP (1) JPS5618979A (es)
AR (1) AR225314A1 (es)
AT (1) AT375078B (es)
AU (1) AU529725B2 (es)
CA (1) CA1153379A (es)
DD (1) DD151940A5 (es)
DE (1) DE3060097D1 (es)
DK (1) DK146962C (es)
ES (1) ES493139A0 (es)
FI (1) FI67217C (es)
GR (1) GR69280B (es)
HU (1) HU182151B (es)
IE (1) IE49994B1 (es)
IN (1) IN151594B (es)
NO (1) NO153496C (es)
NZ (1) NZ193926A (es)
OA (1) OA06563A (es)
PL (1) PL125597B1 (es)
PT (1) PT71424A (es)
SU (1) SU993817A3 (es)
YU (1) YU171880A (es)
ZA (1) ZA803434B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6103702A (en) * 1999-05-24 2000-08-15 Board Of Trustees Of The University Of Illinois Use of adenosine deaminase inhibitors to treat systemic inflammatory response syndrome
WO2001007054A1 (en) * 1999-07-22 2001-02-01 Supergen, Inc. Methods for treating autoimmune diseases
FR2805460A1 (fr) * 2000-02-25 2001-08-31 Oreal Compositions de teinture des fibres keratiniques contenant des derives d'indolizine cationiques et procede de teinture
FR2838123B1 (fr) * 2002-04-04 2005-06-10 Sanofi Synthelabo Nouveaux derives d'indolozine-1,2,3 substituee, inhibiteurs selectifs du b-fgf
JP4048166B2 (ja) * 2002-11-18 2008-02-13 三井製糖株式会社 血糖値上昇抑制剤及び体脂肪蓄積抑制剤並びに食用材料
FR2859997B1 (fr) * 2003-09-18 2006-02-03 Sanofi Synthelabo Nouveaux derives d'indolizine 1,2,3,6,7,8 substituee, inhibiteurs des fgfs, leur procede de preparation et les compositions pharmaceutiques les contenant.
AR051780A1 (es) * 2004-11-29 2007-02-07 Japan Tobacco Inc Compuestos en anillo fusionados que contienen nitrogeno y utilizacion de los mismos
FR2896247B1 (fr) 2006-01-13 2008-02-29 Sanofi Aventis Sa Composes dimeres agonistes des recepteurs des fgfs (fgfrs), leur procede de preparation et leur application en therapeutique
CA2755132C (en) 2009-03-31 2018-02-13 Kissei Pharmaceutical Co., Ltd. Indolizine derivative and use thereof for medical purposes
US20100261666A1 (en) * 2009-04-14 2010-10-14 The Board Of Trustees Of The University Of Illinois Compositions and methods for the treatment of myocardial dysfunction associated with sirs or sepsis
JP5906191B2 (ja) * 2010-09-29 2016-04-20 キッセイ薬品工業株式会社 （アザ）インドリジン誘導体及びその医薬用途
SG11201802010QA (en) * 2015-09-10 2018-04-27 Jiangsu Atom Bioscience And Pharmaceutical Co Ltd A group of compounds used for the treatment or prevention of hyperuricemia or gout
WO2018090921A1 (zh) 2016-11-16 2018-05-24 江苏新元素医药科技有限公司 Urat1抑制剂及其应用
CN108084186B (zh) * 2016-11-16 2021-06-25 江苏新元素医药科技有限公司 Urat1抑制剂及其应用
CN114213331A (zh) * 2017-05-26 2022-03-22 江苏新元素医药科技有限公司 一类urat1抑制剂及其应用
WO2018214961A1 (zh) * 2017-05-26 2018-11-29 江苏新元素医药科技有限公司 促尿酸排泄的urat1抑制剂
JP7266901B2 (ja) * 2018-01-19 2023-05-01 エボポイント、バイオサイエンシズ、カンパニー、リミテッド 複素環式化合物、調製方法及びその医薬的な応用
CN110283167A (zh) * 2018-11-14 2019-09-27 贵州省中国科学院天然产物化学重点实验室 一种抗心率失常药物布托普洛嗪的制备方法
WO2022169974A1 (en) 2021-02-05 2022-08-11 Nexys Therapeutics, Inc. Inhibitors of urat1 and pharmaceutical uses thereof
WO2023221078A1 (en) * 2022-05-20 2023-11-23 Jiangsu Atom Bioscience And Pharmaceutical Co., Ltd. Solid forms of a compound for treating or preventing hyperuricemia or gout

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU430639A1 (ru) 1972-06-05 1978-02-28 Московский Ордена Ленина И Ордена Трудового Красного Знамени Государственный Университет Им.М.В.Ломоносова Способ получени 1-пиридилиндолизинов
GB1518443A (en) * 1976-02-19 1978-07-19 Labaz Indolizine derivatives and process for preparing the same
FI61030C (fi) 1976-02-19 1982-05-10 Sanofi Sa Foerfarande foer framstaellning av terapeutiskt verkande 2-substituerade-1- eller 3-benzoyl-indolizinderivat

Also Published As

Publication number Publication date
ATA354380A (de) 1983-11-15
IE801349L (en) 1981-01-06
NO153496B (no) 1985-12-23
HU182151B (en) 1983-12-28
AT375078B (de) 1984-06-25
CA1153379A (en) 1983-09-06
NZ193926A (en) 1984-05-31
NO153496C (no) 1986-05-14
PT71424A (en) 1980-07-01
GR69280B (es) 1982-05-13
EP0022762B1 (fr) 1981-11-25
EP0022762A1 (fr) 1981-01-21
ZA803434B (en) 1981-05-27
NO802015L (no) 1981-01-07
FI67217C (fi) 1985-02-11
DE3060097D1 (en) 1982-01-28
SU993817A3 (ru) 1983-01-30
DK291180A (da) 1981-01-07
YU171880A (en) 1983-10-31
IE49994B1 (en) 1986-01-22
IN151594B (es) 1983-06-04
DD151940A5 (de) 1981-11-11
FI67217B (fi) 1984-10-31
DK146962C (da) 1984-08-06
PL225479A1 (es) 1981-10-30
US4400387A (en) 1983-08-23
ES8105710A1 (es) 1981-06-16
DK146962B (da) 1984-02-27
AU529725B2 (en) 1983-06-16
AU5948780A (en) 1981-01-15
ES493139A0 (es) 1981-06-16
JPS5618979A (en) 1981-02-23
OA06563A (fr) 1981-07-31
FI802165A (fi) 1981-01-07
PL125597B1 (en) 1983-05-31

Similar Documents

Publication Publication Date Title
ES489934A0 (es) Procedimiento para la preparacion de derivados de pipreridi-na
ES490536A0 (es) Procedimiento para la preparacion de derivados de la glici- namida
ES498224A0 (es) Procedimiento para la preparacion de sulfonilureas
ES491913A0 (es) Procedimiento para la preparacion de betainas
ES492891A0 (es) Procedimiento para la preparacion de derivados triyodados deacido 5-amino- isoftalico
AR227645A1 (es) Procedimiento para la preparacion de oxoalcohilxantinas
ES492566A0 (es) Procedimiento para la preparacion de nuevos derivados de en-cafalina
AR225314A1 (es) Procedimiento para la preparacion de nuevos derivados de indolizina
ES495179A0 (es) Procedimiento para la preparacion de polieterpoliaminas
ES493774A0 (es) Procedimiento para la preparacion de 3-amino-sidnoniminas
ES497100A0 (es) Procedimiento para la preparacion de sulfonilureas
ES491143A0 (es) Procedimiento para la preparacion de derivados de bencimida-zol
ES491154A0 (es) Procedimiento para la preparacion de derivados furanonicos
ES487746A0 (es) Procedimiento para la preparacion de bis-estiril-benceno
ES493300A0 (es) Procedimiento para la preparacion de acilureas
MX6221E (es) Procedimiento para la preparacion de derivados de homoserina
ES491527A0 (es) Procedimiento para la preparacion de tiazoliliden-oxo-pro- pionitrilos
ES490421A0 (es) Procedimiento para la preparacion de diestirilbencenos
ES490420A0 (es) Procedimiento para la preparacion de diestirilbifenilos
ES494856A0 (es) Procedimiento para la preparacion de n-aril-n-acil-3-amino- oxazolidin-2-onas
AR225159A1 (es) Procedimiento para la preparacion de l-alpha-gliceril-fosforilcolina
ES490620A0 (es) Procedimiento para la preparacion de 3-alcoxi-6-alquiliden- hidracionopiridacina
ES497659A0 (es) Procedimiento para la preparacion de sulfonilureas
AR223434A1 (es) Procedimiento para la preparacion de derivados de i-piperidino-ftalazina
ES493001A0 (es) Procedimiento para la preparacion de metilglioxal